30 related articles for article (PubMed ID: 19040559)
1. Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients' Survival.
Trailin AV; Ostapenko TI; Nykonenko TN; Nesterenko SN; Nykonenko OS
Dis Markers; 2017; 2017():9264904. PubMed ID: 28694560
[TBL] [Abstract][Full Text] [Related]
2. The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.
Ward-Kavanagh LK; Lin WW; Šedý JR; Ware CF
Immunity; 2016 May; 44(5):1005-19. PubMed ID: 27192566
[TBL] [Abstract][Full Text] [Related]
3. Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation.
Fernández-Ruiz M; Kumar D; Humar A
Clin Transl Immunology; 2014 Feb; 3(2):e12. PubMed ID: 25505960
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.
Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vitko S; Skibová J; Striz I
Transpl Immunol; 2005 Jun; 14(2):117-21. PubMed ID: 15935302
[TBL] [Abstract][Full Text] [Related]
5. Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients.
Wang D; Wu WZ; Chen JH; Yang SL; Wang QH; Zeng ZX; Tan JM
Transpl Immunol; 2010 Feb; 22(3-4):115-20. PubMed ID: 20036333
[TBL] [Abstract][Full Text] [Related]
6. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation.
Kim MS; Kim HJ; Kim SI; Ahn HJ; Ju MK; Kim HJ; Jeon KO; Kim YS
Transplantation; 2006 Dec; 82(12):1602-5. PubMed ID: 17198243
[TBL] [Abstract][Full Text] [Related]
7. Pre-transplant level of soluble CD30 is associated with infection after heart transplantation.
Nikaein A; Spiridon C; Hunt J; Rosenthal J; Anderson A; Eichhorn E; Magee M; Dewey T; Mack M
Clin Transplant; 2007; 21(6):744-7. PubMed ID: 17988268
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
Ayed K; Abdallah TB; Bardi R; Abderrahim E; Kheder A
Transplant Proc; 2006 Sep; 38(7):2300-2. PubMed ID: 16980071
[TBL] [Abstract][Full Text] [Related]
9. CD30, a marker to detect the high-risk kidney transplant recipients.
Spiridon C; Nikaein A; Lerman M; Hunt J; Dickerman R; Mack M
Clin Transplant; 2008; 22(6):765-9. PubMed ID: 19040559
[TBL] [Abstract][Full Text] [Related]
10. Advances in pre- and posttransplant immunologic testing in kidney transplantation.
Süsal C; Pelzl S; Simon T; Opelz G
Transplant Proc; 2004; 36(1):29-34. PubMed ID: 15013292
[TBL] [Abstract][Full Text] [Related]
11. Pretransplantation soluble CD30 level as a predictor of acute rejection in kidney transplantation: a meta-analysis.
Chen Y; Tai Q; Hong S; Kong Y; Shang Y; Liang W; Guo Z; He X
Transplantation; 2012 Nov; 94(9):911-8. PubMed ID: 23052636
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD30 for the prediction and detection of kidney transplant rejection.
Arjona A
Drug News Perspect; 2009 Sep; 22(7):409-13. PubMed ID: 19890498
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
